Lutgendorf Susan K, Shinn Eileen, Carter Jeanne, Leighton Susan, Baggerly Keith, Guindani Michele, Fellman Bryan, Matzo Marianne, Slavich George M, Goodman Marc T, Tew William, Lester Jenny, Moore Kathleen M, Karlan Beth Y, Levine Douglas A, Sood Anil K
Department of Psychological and Brain Sciences, University of Iowa, Iowa City, IA, USA; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA, USA; Department of Urology, University of Iowa, Iowa City, IA, USA; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA.
Department of Behavioral Science, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA.
Gynecol Oncol. 2017 Jul;146(1):101-108. doi: 10.1016/j.ygyno.2017.05.008. Epub 2017 May 17.
Long-term survival of women with advanced-stage ovarian cancer is relatively rare. Little is known about quality of life (QOL) and survivorship concerns of these women. Here, we describe QOL of women with advanced-stage ovarian cancer surviving for 8.5 years or longer and compare women with 0-1 recurrence to those with multiple recurrences.
Participants (n=56) recruited from 5 academic medical centers and the Ovarian Cancer Research Fund Alliance completed surveys regarding QOL (FACT-O), mood (CESD), social support (SPS), physical activity (IPAQ-SF), diet, and clinical characteristics. Median survival was 14.0 years (range 8.8-33.3).
QOL and psychological adjustment of long-term survivors was relatively good, with mean FACT-G scores (multiple recurrences: 80.81±13.95; 0-1 recurrence: 89.05 ±10.80) above norms for healthy community samples (80.1±18.1). Survivors with multiple recurrences reported more compromised QOL in domains of physical and emotional well-being (p <.05), and endorsed a variety of physical and emotional concerns compared to survivors with 0-1 recurrence. Difficulties in sexual functioning were common in both groups. Almost half (43%) of the survivors reported low levels of physical activity.
Overall, women with advanced-stage ovarian cancer who have survived at least 8.5 years report good QOL and psychological adjustment. QOL of survivors with multiple recurrences is somewhat impaired compared to those with 0-1 recurrence. Limitations include a possible bias towards participation by healthier survivors, thus under-representing the level of compromise in long-term survivors. Health care practitioners should be alert to psychosocial issues faced by these long-term survivors to provide interventions that enhance QOL.
晚期卵巢癌女性的长期生存相对少见。对于这些女性的生活质量(QOL)和生存问题知之甚少。在此,我们描述了生存8.5年或更长时间的晚期卵巢癌女性的生活质量,并比较了复发0 - 1次的女性与多次复发的女性。
从5个学术医疗中心和卵巢癌研究基金联盟招募的参与者(n = 56)完成了关于生活质量(FACT - O)、情绪(CESD)、社会支持(SPS)、身体活动(IPAQ - SF)、饮食和临床特征的调查。中位生存期为14.0年(范围8.8 - 33.3)。
长期幸存者的生活质量和心理调适相对良好,FACT - G平均得分(多次复发:80.81±13.95;0 - 1次复发:89.05±10.80)高于健康社区样本的标准(80.1±18.1)。多次复发的幸存者在身体和情感健康领域报告的生活质量受损更严重(p <.05),与复发0 - 1次的幸存者相比,认可各种身体和情感方面的担忧。性功能障碍在两组中都很常见。几乎一半(43%)的幸存者报告身体活动水平较低。
总体而言,至少存活8.5年的晚期卵巢癌女性报告生活质量良好且心理调适良好。与复发0 - 1次的幸存者相比,多次复发的幸存者的生活质量有所受损。局限性包括可能存在更健康的幸存者参与的偏差,因此未能充分代表长期幸存者的受损程度。医疗保健从业者应警惕这些长期幸存者面临的心理社会问题,以提供提高生活质量的干预措施。